Financhill
Back

Corcept Therapeutics 10K Form

Sell
50

CORT
Corcept Therapeutics

Last Price:
$54.98
Seasonality Move:
9.53%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

2024-05-01 10Q CORT/Corcept Therapeutics Quarterly
2023-11-01 10Q CORT/Corcept Therapeutics Quarterly
2023-08-02 10Q CORT/Corcept Therapeutics Quarterly
2023-05-03 10Q CORT/Corcept Therapeutics Quarterly
2022-11-03 10Q CORT/Corcept Therapeutics Quarterly
2022-08-04 10Q CORT/Corcept Therapeutics Quarterly

Receive CORT News And Ratings

See the #1 stock for the next 7 days that we like better than CORT

CORT Financial Statistics

Sales & Book Value

Annual Sales: $675M
Cash Flow: $59.2M
Price / Cash Flow: 32.12
Annual Sales: $6.47
Price / Book: 8.6

Profitability

EPS (TTM): 1.24000
Net Income (TTM): $141.2M
Gross Margin: $664.2M
Return on Equity: 23.78%
Return on Assets: 19.52%

Corcept Therapeutics Earnings Forecast

Key Corcept Therapeutics Financial Ratios

  • The Gross Profit Margin over the past 20 years for CORT is 98.39%.
  • The Selling, General & Administrative Expenses for CORT have been equal to 41.53% of Gross Profit Margin.
  • The Research & Development expenses have been 36.57% of Revenue.
  • The Interest Expense is 0.04% of Operating Income.
  • The Net Earning history of CORT is 20.92% of Total Revenues.
  • Per Share Earnings over the last 24 years have been positive in 13 years.

Corcept Therapeutics Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Pharmaceuticals
Sector: Health Care
Current Symbol: CORT
CUSIP: 218352
Website: corcept.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 3.35
Quick Ratio: 3.11

Price-to-Earnings

Trailing P/E Ratio: 45.06
Forward P/E Ratio: 15.64

CORT Technical Analysis vs Fundamental Analysis

Sell
50
Corcept Therapeutics (CORT) is a Sell

Is Corcept Therapeutics a Buy or a Sell?